Okeiro
French tech company | Builders Republic
About
Precision-medicine company building a clinical decision-support platform for transplant and chronic-disease care — its predictive models, validated with French hospital research partners, estimate the risk of organ failure (kidney, lung, heart, liver) so clinicians can intervene earlier and personalize patient follow-up.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2023
- City
- AMIENS
- Region
- IDF
- Tracked rounds
- 1
- Amount raised
- 10 M€ raised since 2020
Funding rounds
- Series A — 2025